Results 231 to 240 of about 167,841 (267)

Melanoma vaccination: state-of-the-art and experimental approaches

Expert Review of Anticancer Therapy, 2001
Vaccination therapy for human malignancies is an ever-evolving technology. Great strides are being made in our understanding of the various components of the immune system and how best to manipulate these components.
openaire   +2 more sources

Candida albicans enhances experimental hepatic melanoma metastasis

Clinical & Experimental Metastasis, 2009
Candida albicans infections are very frequent in cancer patients, whose immune system is often compromised, but whether this fungal pathogen affects cancer progression is unknown. C. albicans infection involves endogenous production of inflammatory cytokines such as tumour necrosis factor alpha (TNF-alpha) and interleukin-18 (IL-18).
Juan, Rodríguez-Cuesta, Fernando L, Hernando, Lorea, Mendoza, Natalia, Gallot, Ana Abad Díaz, de Cerio, Guillermo, Martínez-de-Tejada, Fernando, Vidal-Vanaclocha   +6 more
openaire   +2 more sources

Effect of anti-fibrinolytic therapy on experimental melanoma metastasis

Clinical & Experimental Metastasis, 2008
Anti-fibrinolytic agents such as aprotinin and epsilon-aminocaproic acid (EACA) are used clinically to decrease peri-operative bleeding. Use of these treatments during cancer-related surgeries has led to investigation of the effect of fibrinolysis inhibition on cancer cell spread.
Jennifer M, Kirstein, Kevin C, Graham, Lisa T, Mackenzie, Danielle E, Johnston, Leslie J, Martin, Alan B, Tuck, Ian C, MacDonald, Ann F, Chambers   +7 more
openaire   +2 more sources

Ultraviolet Radiation and the Development of Non-Melanoma and Melanoma Skin Cancer: Clinical and Experimental Evidence

Skin Pharmacology, 2009
Clinical and experimental evidence explaining and supporting the role of UV radiation as a causal factor for the induction and promotion of nonmelanoma and malignant melanoma skin cancer are presented. While there is excellent animal experimental data and human epidemiologic evidence supporting the causal relationship of UVR (UVB, as well as UVA ...
openaire   +2 more sources

Experimental models for primary melanoma.

Photodermatology, photoimmunology & photomedicine, 1993
The nonmelanoma skin cancers squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) are by far the most common malignancies that occur in the United States each year. The third most common skin cancer, malignant melanomas (MM), accounted for 3% of all reportable cancers in the United States in 1991. The incidence of and mortality due to MM have
openaire   +1 more source

[Heparin inhibits metastatization of experimental melanoma].

Magyar onkologia, 2005
Heparin treatment, at human equivalent doses, modulates coagulation parameters in mice similarly to the human situation. Heparins were tested in various melanoma metastasis models for their antimetastatic activity. Heparins were active against melanoma metastasis without influencing the primary tumor. Tumor cell-induced platelet aggregation was not the
József, Tóvári, Bíborka, Bereczky, Réka, Gilly, Judit, Skopál, Agnes, Vágó, József, Tímár   +5 more
openaire   +1 more source

Subchoroidal Transplantation of Experimental Malignant Melanoma

American Journal of Ophthalmology, 1970
D L, Krohn, R, Brandt, D A, Morris, A S, Keston   +3 more
openaire   +2 more sources

Experimental recapture therapy of melanoma

Melanoma Research, 1997
G Lipkin, M Rosenberg
openaire   +1 more source

Experimental models of human melanoma

Toxicology Letters, 2016
D.E. Coricovac, I. Pinzaru, I.Z. Pavel, R. Ghiulai, A.M. Cimpean, C. Soica, C.A. Dehelean, S. Avram   +7 more
openaire   +1 more source

Control of experimental melanoma by host CXCR2

Current Oncology Reports, 2009
openaire   +2 more sources